Bulevirtide

Overview

Bulevirtide (Myrcludex B) is a NTCP inhibitor, a linear lipopeptide of 47 amino acids . Bulevirtide inhibits HBV and HDV entry into liver cells, blocks HBV infection in hepatocytes, and participates in HBV transcriptional suppression. Bulevirtide can be used in HDV infection and compensated cirrhosis research.

Application

Products | Products > Peptides | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HBV

Product Information

• Catalog No.: HY-P3465
• CAS No.: 2012558-47-1
• Molecular Formula: C248H355N65O72
• Molecular Weight: 5398.86
• Purity: 99.70%
• Storage: Sealed storage, away from moisture and light, under nitrogen. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
• Solubility: 2.5 mg/mL (0.46 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source